Dr. Qingqing Yao
Department of Pharmacy, The First Affiliated Hospital, Soochow University
E-mail：yaoqq1003@163.com
Biography
Qingqing Yao, pharmacist in charge, PhD in Pharmaceutical Analysis, is a clinical pharmacist in Respiratory Medicine at the Department of Pharmacy, The First Affiliated Hospital of Soochow University. She completed the standardized training for clinical pharmacists in respiratory medicine at the Jiangsu Province Hospital in 2021, and the teacher training for clinical pharmacists at the First Affiliated Hospital, Zhejiang University School of Medicine in 2025. Her work focuses on whole-course pharmaceutical care, rational use of antibacterial drugs, and evaluation of adverse drug reactions. Her main research directions include clinical pharmacy and individualized therapy, as well as therapeutic drug monitoring of antimicrobial drugs. She serves as a Young Member of the Analytical Pharmacology Committee, Chinese Pharmacological Society, a Young Member of the Pharmaceutical Analysis Technology Branch, Chinese Pharmaceutical Biotechnology Association, and an expert in the monitoring of adverse drug (device/cosmetic) reactions (events) at the Suzhou Adverse Drug Reaction Monitoring Center. She is a recipient of the Jiangsu Provincial "Double Creation" PhD program. She presides 1 Suzhou Pharmaceutical Association Science and Technology Project project, and 1 project each from the Jiangsu Pharmaceutical Association and Suzhou Pharmaceutical Association, and has published more than 10 papers as the first or corresponding author.
Select Publications (* represents corresponding author)
1. Gao J#, Zhu Y#, Gong YH, Song L, Wu ZY, Shi J, Liu LS, Yao QQ*. Impact of body mass index and serum albumin levels on isavuconazole plasma concentrations in patients with haematological malignancies. J Antimicrob Chemother. 2026;81(3):dkag032.
2. Shi JF#, Gao J#, Zhu Y, Zhao CY, Wang W, Chen SQ, Yao QQ*. Rational evaluation of the clinical application of ceftazidime-avibactam for the treatment of carbapenem-resistant Klebsiella pneumoniae infections: A real-world retrospective study. Diagn Microbiol Infect Dis. 2025;111(3):116659.
3. Yao QQ#, Gao J#, Liu LS, Shi JF, Zafar H, Khan MI, Zhu JG*, Raza F*, Zhu Y*. Short peptide hydrogel with angular structure for hydrophobic antitumor drug delivery and controlled release. Colloids Surf B Biointerfaces. 2025;254:114793.
4. Li C, Yao QQ*, Li J*. Druggability properties of a L309K mutation in the antibody CH2 domain. 3 Biotech. 2024;14(6):152.
5. Yao QQ#, Li L#, Xu MC, Hu HH, Zhou H, Yu LS*, Zeng S*. The metabolism and hepatotoxicity of ginkgolic acid (17 : 1) in vitro. Chin J Nat Med. 2018;16(11):829-37.
6. Yao QQ#, Liu ZH#, Xu MC, Hu HH, Zhou H, Jiang HD, Yu LS, Zeng S*. Mechanism for ginkgolic acid (15 : 1)-induced MDCK cell necrosis: Mitochondria and lysosomes damages and cell cycle arrest. Chin J Nat Med. 2017;15(5):375-83.
7. Bian YC#, Yao QQ#, Shang HT#, Lei JX, Hu HH, Guo KN, Jiang HD, Yu LS*, Wei H,* Zeng S. Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes. Drug Metab Dispos. 2015;43(9):1336-40.
8. Yao QQ, Shi JF, Liu LS, Zhang Y, Gao J*. Serum concentration of isavuconazole detected by UPLC-MS/MS and its clinical application. Chin J Hosp Pharm. 2025;45(8): 872-6.
9. Yao QQ, Ding XL, Zhang Y, Shi JF, Gao J*. A retrospective study of tacrolimus trough level changes in renal transplant recipients with diarrhea. Chin J Hosp Pharm. 2024;44(15): 1785-9.
10. Shi JF, Gao J, Wang W, Zhu Y, Xu J, Yao QQ*. Evaluations of etiological characteristics and anti-infection regimens of diabetic foot infection at a tertiary hospital. Chin J Hosp Pharm. 2024;44(9): 1075-81.
11. Yao QQ, Chen SQ, Shi JF, Gao J*. Analysis of clinical characteristics of pyogenic liver abscess and evaluation of selection of anti-infection drugs in a tertiary hospital. Chin J Hosp Pharm, 2022,42(20): 2153-7.
12. Bian YC#, Yao QQ#, Shi J, Hang YF, Xue L, Huang CR, Zhang H, Miao LY*. Correlation Analysis Between the Concentration of Vancomycin in Peritoneal Dialysate and Serum in Patients with Peritoneal Dialysis-Associated Peritonitis. Chin Pharm J. 2022,57(6): 486-90.
